We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+9.82%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+548.24%
AUM
$478B
AUM Growth
+$50B
Cap. Flow
+$13.3B
Cap. Flow %
2.79%
Top 10 Hldgs %
18.61%
Holding
4,322
New
132
Increased
3,091
Reduced
523
Closed
113

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$848M
2
BMY icon
Bristol-Myers Squibb
BMY
+$631M
3
TFC icon
Truist Financial
TFC
+$445M
4
AMZN icon
Amazon
AMZN
+$334M
5
NOW icon
ServiceNow
NOW
+$251M

Sector Composition

Rank Sector Weight
1 Technology 19.79%
2 Financials 15.45%
3 Healthcare 13.87%
4 Consumer Discretionary 9.9%
5 Industrials 9.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NBSE
3901
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$116K ﹤0.01%
810
+12
+2% +$1.41K
CLIR icon
3902
ClearSign Technologies
CLIR
$25.3M
$115K ﹤0.01%
15,148
CRVO icon
3903
CervoMed
CRVO
$23M
$115K ﹤0.01%
3,349
+3,215
+2,399% +$196K
GLMD icon
3904
Galmed Pharmaceuticals
GLMD
$4.62M
$115K ﹤0.01%
111
MBRX icon
3905
Moleculin Biotech
MBRX
$9.61M
$115K ﹤0.01%
56
MMLP icon
3906
Martin Midstream Partners
MMLP
$93.5M
$115K ﹤0.01%
28,709
-22,679
-44% -$99.3K
RDCM icon
3907
Radcom
RDCM
$213M
$115K ﹤0.01%
13,668
AVAL icon
3908
Grupo Aval
AVAL
$5.82B
$113K ﹤0.01%
+13,069
New +$105K
STKL
3909
DELISTED
SunOpta
STKL
$113K ﹤0.01%
45,709
-37,981
-45% -$84.6K
IRIX icon
3910
IRIDEX
IRIX
$15M
$111K ﹤0.01%
49,568
LIVE icon
3911
Live Ventures
LIVE
$29.9M
$111K ﹤0.01%
14,842
CEPU
3912
Central Puerto
CEPU
$2.16B
$110K ﹤0.01%
22,701
IMNN icon
3913
Imunon
IMNN
$6.47M
$110K ﹤0.01%
331
STRM
3914
DELISTED
Streamline Health Solutions
STRM
$110K ﹤0.01%
5,315
ACH
3915
DELISTED
Alum Corp of China Ltd
ACH
$109K ﹤0.01%
+12,598
New +$100K
NGD
3916
DELISTED
New Gold Inc
NGD
$108K ﹤0.01%
122,409
-226,893
-65% -$205K
ALR
3917
DELISTED
AlerisLife Inc
ALR
$107K ﹤0.01%
+28,880
New +$139K
SMRT
3918
DELISTED
Stein Mart Inc
SMRT
$107K ﹤0.01%
160,928
NDRA icon
3919
ENDRA Life Sciences
NDRA
$5.65M
$105K ﹤0.01%
2
HSTO
3920
DELISTED
Histogen Inc. Common Stock
HSTO
$105K ﹤0.01%
1,322
+127
+11% +$8.9K
TRIL
3921
DELISTED
Trillium Therapeutics Inc.
TRIL
$105K ﹤0.01%
102,725
LLEX
3922
DELISTED
Lilis Energy, Inc. Common Stock
LLEX
$105K ﹤0.01%
277,269
CRWS icon
3923
Crown Crafts
CRWS
$31.6M
$104K ﹤0.01%
17,001
+2,283
+16% +$15K
ZDGE icon
3924
Zedge
ZDGE
$38.3M
$103K ﹤0.01%
67,220
-808
-1% -$1.38K
RDHL
3925
Redhill Biopharma
RDHL
$4.44M
$102K ﹤0.01%
17

Similar funds

Geode Capital Management's Q4 2019 Portfolio in Review

As of Q4 2019, Geode Capital Management held 4,322 positions worth $478B, up 12% from $428B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Geode Capital Management's Q4 2019 filing shows 132 new, 3,091 increased, 523 reduced and 113 closed positions. Its largest new stake was Apollo Global Management: 1,482,213 shares worth $70.7M. The largest sale was Celgene Corp, an estimated $1.15B.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • Geode Capital Management's largest Q4 2019 buy was Apollo Global Management: 1,482,213 shares worth $70.7M.
  • Geode Capital Management added most to Microsoft in Q4 2019, an estimated $848M increase.
  • Geode Capital Management's biggest Q4 2019 reduction was Oracle, cutting an estimated $136M.
  • Geode Capital Management fully exited Celgene Corp in Q4 2019, selling an estimated $1.15B.
  • Geode Capital Management's ten largest holdings make up 19% of its $478B portfolio in Q4 2019.
  • Geode Capital Management opened 132 new positions and closed 113 in Q4 2019.
  • Geode Capital Management's portfolio value rose 12% quarter-over-quarter to $478B.

Based on Geode Capital Management's 13F filing for Q4 2019, filed 13 Feb 2020.